Abstract

The FDA approved drug rapamycin increases lifespan in rodents and delays age-related dysfunction in rodents and humans. Nevertheless, important questions remain regarding the optimal dose, duration, and mechanisms of action in the context of healthy aging. Here we show that 3 months of rapamycin treatment is sufficient to increase life expectancy by up to 60% and improve measures of healthspan in middle-aged mice. This transient treatment is also associated with a remodeling of the microbiome, including dramatically increased prevalence of segmented filamentous bacteria in the small intestine. We also define a dose in female mice that does not extend lifespan, but is associated with a striking shift in cancer prevalence toward aggressive hematopoietic cancers and away from non-hematopoietic malignancies. These data suggest that a short-term rapamycin treatment late in life has persistent effects that can robustly delay aging, influence cancer prevalence, and modulate the microbiome.

Data availability

The following data sets were generated

Article and author information

Author details

  1. Alessandro Bitto

    Department of Pathology, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Takashi K Ito

    Department of Pathology, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Victor V Pineda

    Department of Pathology, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Nicolas J Letexier

    Department of Pathology, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Heather Z Huang

    Department of Pathology, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Elissa Sutlief

    Department of Pathology, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Herman Tung

    Department of Pathology, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Nicholas Vizzini

    Department of Pathology, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Belle Chen

    Department of Pathology, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Kaleb Smith

    Department of Pathology, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Daniel Meza

    Department of Pathology, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Masanao Yajima

    Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Richard P Beyer

    Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Kathleen F Kerr

    Department of Biostatistics, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  15. Daniel J Davis

    Department of Veterinary Pathobiology, University of Missouri, Columbia, United States
    Competing interests
    The authors declare that no competing interests exist.
  16. Catherine H Gillespie

    Department of Veterinary Pathobiology, University of Missouri, Columbia, United States
    Competing interests
    The authors declare that no competing interests exist.
  17. Jessica M Snyder

    Department of Comparative Medicine, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  18. Piper M Treuting

    Department of Comparative Medicine, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  19. Matt Kaeberlein

    Department of Pathology, University of Washington, Seattle, United States
    For correspondence
    kaeber@uw.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1311-3421

Funding

Samsung

  • Matt Kaeberlein

National Institute on Aging (P30AG013280)

  • Matt Kaeberlein

University of Washington

  • Daniel J Davis

National Institute on Aging (T32AG000057)

  • Alessandro Bitto

Japan Society for the Promotion of Science

  • Takashi K Ito

Uehara Memorial Foundation

  • Takashi K Ito

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: This study was performed in accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#4359-01) of the University of Washington.

Copyright

© 2016, Bitto et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 19,949
    views
  • 2,268
    downloads
  • 316
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Alessandro Bitto
  2. Takashi K Ito
  3. Victor V Pineda
  4. Nicolas J Letexier
  5. Heather Z Huang
  6. Elissa Sutlief
  7. Herman Tung
  8. Nicholas Vizzini
  9. Belle Chen
  10. Kaleb Smith
  11. Daniel Meza
  12. Masanao Yajima
  13. Richard P Beyer
  14. Kathleen F Kerr
  15. Daniel J Davis
  16. Catherine H Gillespie
  17. Jessica M Snyder
  18. Piper M Treuting
  19. Matt Kaeberlein
(2016)
Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice
eLife 5:e16351.
https://doi.org/10.7554/eLife.16351

Share this article

https://doi.org/10.7554/eLife.16351

Further reading

    1. Cancer Biology
    2. Cell Biology
    Kourosh Hayatigolkhatmi, Chiara Soriani ... Simona Rodighiero
    Tools and Resources

    Understanding the cell cycle at the single-cell level is crucial for cellular biology and cancer research. While current methods using fluorescent markers have improved the study of adherent cells, non-adherent cells remain challenging. In this study, we addressed this gap by combining a specialized surface to enhance cell attachment, the FUCCI(CA)2 sensor, an automated image analysis pipeline, and a custom machine learning algorithm. This approach enabled precise measurement of cell cycle phase durations in non-adherent cells. This method was validated in acute myeloid leukemia cell lines NB4 and Kasumi-1, which have unique cell cycle characteristics, and we tested the impact of cell cycle-modulating drugs on NB4 cells. Our cell cycle analysis system, which is also compatible with adherent cells, is fully automated and freely available, providing detailed insights from hundreds of cells under various conditions. This report presents a valuable tool for advancing cancer research and drug development by enabling comprehensive, automated cell cycle analysis in both adherent and non-adherent cells.

    1. Cancer Biology
    2. Computational and Systems Biology
    Rosalyn W Sayaman, Masaru Miyano ... Mark LaBarge
    Research Article

    Effects from aging in single cells are heterogenous, whereas at the organ- and tissue-levels aging phenotypes tend to appear as stereotypical changes. The mammary epithelium is a bilayer of two major phenotypically and functionally distinct cell lineages: luminal epithelial and myoepithelial cells. Mammary luminal epithelia exhibit substantial stereotypical changes with age that merit attention because these cells are the putative cells-of-origin for breast cancers. We hypothesize that effects from aging that impinge upon maintenance of lineage fidelity increase susceptibility to cancer initiation. We generated and analyzed transcriptomes from primary luminal epithelial and myoepithelial cells from younger <30 (y)ears old and older >55y women. In addition to age-dependent directional changes in gene expression, we observed increased transcriptional variance with age that contributed to genome-wide loss of lineage fidelity. Age-dependent variant responses were common to both lineages, whereas directional changes were almost exclusively detected in luminal epithelia and involved altered regulation of chromatin and genome organizers such as SATB1. Epithelial expression of gap junction protein GJB6 increased with age, and modulation of GJB6 expression in heterochronous co-cultures revealed that it provided a communication conduit from myoepithelial cells that drove directional change in luminal cells. Age-dependent luminal transcriptomes comprised a prominent signal that could be detected in bulk tissue during aging and transition into cancers. A machine learning classifier based on luminal-specific aging distinguished normal from cancer tissue and was highly predictive of breast cancer subtype. We speculate that luminal epithelia are the ultimate site of integration of the variant responses to aging in their surrounding tissue, and that their emergent phenotype both endows cells with the ability to become cancer-cells-of-origin and represents a biosensor that presages cancer susceptibility.